|
⚲
|
| Keyboard |
| Schilke Tobin
✚
|
|
|---|---|
| CIK # | 0001678984 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001678984] | |
| 4 | [0001678984] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schilke Tobin | |
| Crinetics Pharmaceuticals Inc | |
| Revance Therapeutics Inc | |
| Achaogen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-03-03 | Sell | 6,713 | $39.67 | 266,305 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2026-02-23 | Grant | 50,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-02-23 | Grant | 32,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-03-10 | Grant | 80,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-03-10 | Grant | 52,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 103,555 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 20,883 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Grant | 20,883 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 97,999 | $3.65 | 357,696 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-03 | Grant | 6,888 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-12-31 | Grant | 1,000 | $2.18 | 2,180 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-06-30 | Grant | 1,000 | $2.18 | 2,180 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-03-18 | Sell | 9,361 | $5.04 | 47,179 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-03-15 | Tax withheld | 3,822 | $5.31 | 20,295 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-02-29 | Grant | 17,447 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-01-31 | Grant | 96,667 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Performance Stock Units · derivative
|
2024-01-31 | Grant | 145,001 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-12-31 | Grant | 434 | $7.47 | 3,242 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-08-11 | Grant | 22,620 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-08-11 | Tax withheld | 11,215 | $18.91 | 212,076 |
| showing 20 of 83 most recent transactions | |||||